Zobrazeno 1 - 10 of 24 pro vyhledávání: '"O Gioti"'
1
Automated right ventricular strain by speckle tracking echocardiography in patients with systemic scleroderma
Autor: A Tsoukas, E Koutsogiannaki, I Giannakopoulou, O Gioti, D Iliopoulos, R Saad, V Chalkitis, A Peteinaki, E Karapedi, N Papaioannou
Publikováno v: European Heart Journal. 43
Introduction In patients with scleroderma the morphological remodeling and alteration of right ventricular (RV) function begins even before the setting of pulmonary artery hypertension (PAH). These alterations are associated with worse outcomes and h
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d492b63567491b7e464cdd78339dae2f
https://doi.org/10.1093/eurheartj/ehac544.2631
Zobrazit plný text záznamu
2
AB0238 HEALTH-RELATED QUALITY OF LIFE AND CORRELATION WITH DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS
Autor: P. Tzanis, K. Klavdianou, S. Katechis, C. Katsimpari, L. Athanassiou, O. Gioti, I. I. Giannakopoulou, S. Koutsoviti, I. Sofianos, A. Lazarini, A. Fanouriakis, E. Theotikos, E. Kalavri, A. Elezoglou
Publikováno v: Annals of the Rheumatic Diseases. 81:1246.3-1247
BackgroundPatients with active rheumatoid arthritis (RA) are at risk for poor functional outcomes, affecting quality of life (QoL). SF-36 is a validated instrument to measure health-related quality of life (HRQoL) in various domains of physical and m
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fc047fa0506446401ecbcfaed753a1e3
https://doi.org/10.1136/annrheumdis-2022-eular.343
Zobrazit plný text záznamu
3
POS0781 RESIDUAL DISEASE ACTIVITY IN SLE: A REAL-LIFE CROSS-SECTIONAL STUDY IN THREE TERTIARY CENTRES TO EXPLORE THE ROOM FOR NOVEL THERAPIES
Autor: O. Gioti, M. Nikoloudaki, K. Chavatza, E. Theotikos, A. Elezoglou, P. Sidiropoulos, G. Bertsias, D. Boumpas, A. Fanouriakis
Publikováno v: Annals of the Rheumatic Diseases. 81:677.2-678
BackgroundAccording to updated EULAR recommendations, the goal of treatment in systemic lupus erythematosus (SLE) should be remission or low disease activity in all organ systems, achieved with the least possible dose of glucocorticoids.1 The proport
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c0b3ac6e9032d67ec48c9f571ec4100b
https://doi.org/10.1136/annrheumdis-2022-eular.4690
Zobrazit plný text záznamu
4
POS0366 MODERATE RATES OF TREATMENT INTENSIFICATION IN SLE PATIENTS WITH RESIDUAL DISEASE ACTIVITY
Autor: O. Gioti, M. Nikoloudaki, K. Chavatza, E. Kalavri, A. Elezoglou, P. Sidiropoulos, G. Bertsias, D. Boumpas, A. Fanouriakis
Publikováno v: Annals of the Rheumatic Diseases. 81:436.1-436
BackgroundThe treat-to-target (T2T) strategy has gained significant attention in SLE,1 while EULAR has set remission or low disease activity as the goal of treatment.2 Nevertheless, the degree to which T2T is followed in real-life clinical settings h
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::87608432e3b0439ba327bfcf61fa3fe4
https://doi.org/10.1136/annrheumdis-2022-eular.5011
Zobrazit plný text záznamu
5
POS0122 CENTRAL NERVOUS SYSTEM DEMYELINATING SYNDROMES IN SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM 'ATTIKON' LUPUS COHORT
Autor: D. Nikolopoulos, D. Kitsos, M. Papathanasiou, N. Kapsala, A. Grivas, O. Gioti, P. Garantziotis, A. Pieta, K. Voumvourakis, D. Boumpas, A. Fanouriakis
Publikováno v: Annals of the Rheumatic Diseases. 81:287.3-287
BackgroundCentral nervous system (CNS) demyelinating syndromes that occur in the context of SLE may represent a manifestation of neuropsychiatric lupus, or an overlap of SLE and multiple sclerosis (MS). The differential diagnosis between the two enti
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::92a6eba95c107bbec704cbb974e17343
https://doi.org/10.1136/annrheumdis-2022-eular.5031
Zobrazit plný text záznamu
6
Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients
Autor: Martin Aringer, Marta Mosca, Konstantina Togia, John Boletis, George Bertsias, Dionysis Nikolopoulos, Andrea Doria, Myrto Kostopoulou, David Jayne, Antonis Fanouriakis, O. Gioti, Angela Tincani, Elisabet Svenungsson, Dimitrios T. Boumpas, Laura Andreoli, Frédéric Houssiau, K. Chavatza
Publikováno v: Annals of the rheumatic diseases, Vol. 80, no.9, p. 1175-1182 (2021)
Annals Rheumatic Disease
BackgroundQuality of care is receiving increased attention in systemic lupus erythematosus (SLE). We developed quality indicators (QIs) for SLE based on the 2019 update of European League Against Rheumatism recommendations.MethodsA total of 44 candid
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4aa005193672de1d253c8e3426641972
http://hdl.handle.net/11568/1115697
Zobrazit plný text záznamu
7
POS0786 UNMET TREATMENT NEEDS IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A CROSS-SECTIONAL ASSESSMENT OF DISEASE ACTIVITY IN SLE PATIENTS DURING THEIR LAST VISIT
Autor: C. Katsimpari, S. Koutsoviti, K. Chavatza, Evangelos Theotikos, Antonia Elezoglou, G. Belevonis, Argyro Lazarini, A. Tatsi, E. Kalavri, A. Fanouriakis, Kalliopi Klavdianou, P. Tzanis, I. I. Giannakopoulou, I. Sofianos, O. Gioti, Dimitrios T. Boumpas
Publikováno v: Annals of the Rheumatic Diseases. 80:646.1-646
Background:The current goal of treatment in SLE is remission or low disease activity (LDA) and prevention of flares, achieved with the lowest possible dose of glucocorticoids. Nevertheless, in current clinical practice a significant number of patient
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::987b6351d0e7c8694025441ac8b59831
https://doi.org/10.1136/annrheumdis-2021-eular.3832
Zobrazit plný text záznamu
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje